Know Cancer

or
forgot password

Sonazoid Enhanced Liver Cancer Trial for Early Detection


N/A
20 Years
N/A
Open (Enrolling)
Both
Hepatocellular Carcinoma, Liver Cirrhosis, Hepatitis B, Hepatitis C

Thank you

Trial Information

Sonazoid Enhanced Liver Cancer Trial for Early Detection


Inclusion Criteria:



1. Age over 20

2. HBV or HCV related liver cirrhosis

3. No history of HCC

4. Diagnosed as liver cirrhosis histologically or clinically Histologically confirmed by
liver biopsy Confirmed by formula of diagnosing cirrhosis Radiological finding
Finding of portal hypertension Platelet<130,000

5. Inpatient or outpatient

6. Patients who signed a written informed consent form

Exclusion Criteria:

1. History of hypersensitivity to egg yolk

2. Pregnant or lactating women and women who may be pregnant

3. Severe liver dysfunction(AST, ALT,or BIL level >10ULN

4. Associated with HCC

5. Patients receiving interferon

6. Age under 20

7. Judged by investigator not to be appropriate for inclusion in this study

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Size of HCC which is detected first

Outcome Time Frame:

10 years

Safety Issue:

Yes

Principal Investigator

Masatoshi Kudo, professor

Investigator Role:

Principal Investigator

Investigator Affiliation:

Japan Liver Oncology Group

Authority:

Japan: Institutional Review Board

Study ID:

JLOG08001

NCT ID:

NCT00822991

Start Date:

January 2009

Completion Date:

December 2019

Related Keywords:

  • Hepatocellular Carcinoma
  • Liver Cirrhosis
  • Hepatitis B
  • Hepatitis C
  • Sonazoid
  • Early detection
  • Hepatocellular carcinoma
  • Liver cirrhosis
  • Carcinoma
  • Hepatitis
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Liver Cirrhosis
  • Fibrosis
  • Liver Neoplasms
  • Carcinoma, Hepatocellular

Name

Location